TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Epic Sciences Stock

Epic Sciences Stock

epicsciences.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $24MM

Epic Sciences, founded in 2008, is a diagnostics company seeking to to improve cancer management. The company aims to provide easily accessible and real-time biopsy material to guide personalized medicine for numerous pharmaceutical companies and major cancer centers. The Epic Sciences platform is designed with the goal of identifying and characterizing rare cells including circulating tumor cells ("CTCs"). Epic Sciences is headquartered in San Diego, California.

Buy or sell Epic Sciences stockLearn more about Epic Sciences IPO
Register for Details

For more details on financing and valuation for Epic Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Epic Sciences.

Register Today

Epic Sciences investors also invested in these private companies

Domain Associates
Deerfield Management
Pagoda Investment
U.S. Department of Health and Human Services
Arcus Ventures
Labcorp Ventures
Altos Capital Partners
Genomic Health
Hermed Capital
VI Ventures

Team

Management Team

Pascal Bamford Ph.D
Chief Scientific Officer and Head of Laboratory Operations
Dena Marrinucci Ph.D
Co-Founder & Member Clinical Advisory Board
Murali Prahalad Ph.D
Chief Executive Officer & President
Ryan Dittamore
Chief of Medical Innovation and Head of Translational Research Partnerships
Ian Miller JD
Chief Business Officer and General Counsel
Dave Henderson
Chief Information Officer

Board Members

Evgeny Zaytsev Ph.D
RusnanoMedInvest
Kim Kamdar Ph.D
Domain Associates
Andrew ElBardissi MD
Deerfield Management
Simon Greenwood Ph.D
Roche Venture Fund

Other companies like Epic Sciences in the BioTech & Pharma sector

ANDE

Sector
Healthcare / BioTech & Pharma
 
 

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$3.67B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.45B

Life Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$500MM

Biosplice Therapeutics

Sector
Healthcare / BioTech & Pharma
 
 

Resilience

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.84B

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$303.94MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Eikon Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$4.74B

News Highlights

BUSINESS WIRE 04/14/2023
Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $24 million Series G which together with its $43 million Series F financing, totals $67 million raised in the last twelve months.
FinSMEs 09/12/2018
Epic Sciences Closes $52M in Series E Financing | FinSMEs
Epic Sciences, a San Diego, CA-based developer of blood tests that predict therapeutic benefit for cancer patients, completed a $52m Series E financing

Trending Companies

Frequently Asked Questions

Updated on: Sep 24, 2023